Cargando…

P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA

Detalles Bibliográficos
Autores principales:	Wang, L., Xu, H., Liang, J., Li, Y., Shi, L., Xiao, B., Huang, J., Xu, X., Zhang, X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429684/ http://dx.doi.org/10.1097/01.HS9.0000848716.65161.13

Ejemplares similares

S272: SAFETY AND EFFICACY OF RM-001 IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA: EARLY RESULTS FROM THE ONGOING OF AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Liu, Rongrong, et al.
Publicado: (2023)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Locatelli, Franco, et al.
Publicado: (2023)

A novel compound heterozygous of β-thalassemia with HbG-Coushatta: case report of Iran
por: Soozangar, Narges, et al.
Publicado: (2023)

P1465: SAFETY AND EFFICACY OF APOTRANSFERRIN INFUSION IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA, THE AIM STUDY
por: Konté, Kadère, et al.
Publicado: (2023)

HBG2 -158 (C>T) polymorphism and its contribution to fetal hemoglobin variability in Iraqi Kurds with beta-thalassemia minor
por: Albarawi, Dilan J., et al.
Publicado: (2018)

P1741: EXAMINING THE BURDEN OF ILLNESS ASSOCIATED WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA FROM THE PATIENT’S PERSPECTIVE
por: Knoth, R. L., et al.
Publicado: (2022)

A Stent Thrombosis 1465 Days After Implantation
por: Ocal Karabay, Kanber, et al.
Publicado: (2011)

TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction
por: Lux, Christopher T., et al.
Publicado: (2018)

$\bar{\rm p}{\rm p}$-annihilation into $\omega\pi^{0}$, $\omega\eta$ and $\omega\eta^{\prime}$ at 600, 1200 and 1940 MeV/$c$
por: Abele, A, et al.
Publicado: (2000)

1465 Pigmented Mold Endocarditis – Case Series and Review of the Literature
por: Hoz, Ricardo La, et al.
Publicado: (2014)

PB2238: ΒETA-THALASSEMIA INTERMEDIA: INTERACTION OF ΑLPHA-GLOBIN GENE TRIPLICATION WITH ΒETA-THALASSEMIA HETEROZYGOUS IN SPAIN
por: Ropero, P., et al.
Publicado: (2022)

MIR29B mediates epigenetic mechanisms of HBG gene activation
por: Starlard‐Davenport, Athena, et al.
Publicado: (2019)

P1510: VAMIFEPORT PREVENTED THE FORMATION OF NON-TRANSFERRIN-BOUND IRON IN A MOUSE MODEL OF ΒETA-THALASSEMIA WITH BLOOD TRANSFUSIONS
por: Kalleda, N., et al.
Publicado: (2022)

Association of polymorphisms in the HBG1‐HBD intergenic region with HbF levels
por: Hu, Li, et al.
Publicado: (2020)

1465. Discovering Outpatient Stewardship Targets: An Evaluation of Community Acquired Pneumonia in the Outpatient Setting
por: Wattengel, Bethany, et al.
Publicado: (2018)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Hematopoietic progenitor cell mobilization for autologous transplantation – a literature review
por: Salvino, Marco Aurélio, et al.
Publicado: (2016)

Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34(+) HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin
por: Lamsfus-Calle, Andrés, et al.
Publicado: (2020)

Pulmonary Functions in Transfusion-Dependent Thalassemia
por: Chandra, Jagdish, et al.
Publicado: (2022)

CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2020)

Transient loading of CD34(+) hematopoietic progenitor cells with polystyrene nanoparticles
por: Deville, Sarah, et al.
Publicado: (2017)

S273: LONG-TERM ERYTHROID RESPONSE DATA FROM PATIENTS (PTS) WITH NON-TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA (NTDT) RECEIVING LUSPATERCEPT IN THE BEYOND TRIAL
por: Taher, Ali T., et al.
Publicado: (2023)

Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.
por: Atkin, N. B., et al.
Publicado: (1979)

Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option
por: Starlard-Davenport, Athena, et al.
Publicado: (2022)

1465. Two- versus Three-Gram Cefazolin Dosing for Surgical Prophylaxis in Colorectal Surgery Procedures
por: Collins, Curtis D, et al.
Publicado: (2023)

The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures
por: Ma, Shaochun, et al.
Publicado: (2005)

Occult Kidney Dysfunction in Children With Transfusion-Dependent Thalassemia
por: Mohd Zikre, Nurwahida, et al.
Publicado: (2021)

Alloimmunization among transfusion-dependent thalassemia patients
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2009)

Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia
por: Sookaromdee, Pathum, et al.
Publicado: (2018)

Quality of life in transfusion-dependent thalassemia patients
por: Alzahrani, Rizqallah A., et al.
Publicado: (2017)

Hypoparathyroidism in a Case of Transfusion Dependent Thalassemia
por: Majumder, Anirban, et al.
Publicado: (2020)

Transfusion Complications in Thalassemia: Patient Knowledge and Perspectives
por: Patterson, Sashoy, et al.
Publicado: (2022)

The transfusion management of beta thalassemia in the United States
por: Lal, Ashutosh, et al.
Publicado: (2021)

Septic Arthritis and the Opioid Epidemic: 1465 Cases of Culture-Positive Native Joint Septic Arthritis From 1990–2018
por: Ross, John J, et al.
Publicado: (2020)

Does Autologous Transfusion Decrease Allogeneic Transfusion in Liposuction Surgery of Lymphedema Patients?
por: Chen, Linfeng, et al.
Publicado: (2022)

The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
por: Rattananon, Parin, et al.
Publicado: (2021)

β-Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2010)

Mutational analysis of thalassemia in transfusion-dependent beta-thalassemia patients from central India
por: Shrivastava, Manisha, et al.
Publicado: (2019)

Serum after Autologous Transplantation Stimulates Proliferation and Expansion of Human Hematopoietic Progenitor Cells
por: Walenda, Thomas, et al.
Publicado: (2011)

P1517: REAL-WORLD COMPLICATION BURDEN AND DISEASE MANAGEMENT IN TRANSFUSION-DEPENDENT ADULTS WITH ΒETA-THALASSEMIA (Β-THAL) IN GREECE: FINAL RESULTS OF THE EPIDEMIOLOGICAL CROSS-SECTIONAL ULYSSES STUDY
por: Kattamis, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7e820pd54f870hb04fqtc18cq9